BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30754661)

  • 1. Stratification of Breast Cancer by Integrating Gene Expression Data and Clinical Variables.
    He Z; Zhang J; Yuan X; Xi J; Liu Z; Zhang Y
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30754661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
    Aure MR; Vitelli V; Jernström S; Kumar S; Krohn M; Due EU; Haukaas TH; Leivonen SK; Vollan HK; Lüders T; Rødland E; Vaske CJ; Zhao W; Møller EK; Nord S; Giskeødegård GF; Bathen TF; Caldas C; Tramm T; Alsner J; Overgaard J; Geisler J; Bukholm IR; Naume B; Schlichting E; Sauer T; Mills GB; Kåresen R; Mælandsmo GM; Lingjærde OC; Frigessi A; Kristensen VN; Børresen-Dale AL; Sahlberg KK;
    Breast Cancer Res; 2017 Mar; 19(1):44. PubMed ID: 28356166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research-based PAM50 signature and long-term breast cancer survival.
    Pu M; Messer K; Davies SR; Vickery TL; Pittman E; Parker BA; Ellis MJ; Flatt SW; Marinac CR; Nelson SH; Mardis ER; Pierce JP; Natarajan L
    Breast Cancer Res Treat; 2020 Jan; 179(1):197-206. PubMed ID: 31542876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
    Tishchenko I; Milioli HH; Riveros C; Moscato P
    PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network based stratification of major cancers by integrating somatic mutation and gene expression data.
    He Z; Zhang J; Yuan X; Liu Z; Liu B; Tuo S; Liu Y
    PLoS One; 2017; 12(5):e0177662. PubMed ID: 28520777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
    Milioli HH; Vimieiro R; Riveros C; Tishchenko I; Berretta R; Moscato P
    PLoS One; 2015; 10(7):e0129711. PubMed ID: 26132585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral clustering using Nyström approximation for the accurate identification of cancer molecular subtypes.
    Shi M; Xu G
    Sci Rep; 2017 Jul; 7(1):4896. PubMed ID: 28687729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural networks and Fuzzy clustering methods for assessing the efficacy of microarray based intrinsic gene signatures in breast cancer classification and the character and relations of identified subtypes.
    Samarasinghe S; Chaiboonchoe A
    Methods Mol Biol; 2015; 1260():285-317. PubMed ID: 25502389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
    Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
    Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions.
    Wang S; Lee D
    PLoS Comput Biol; 2023 May; 19(5):e1011197. PubMed ID: 37253056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer.
    Klopfenstein Q; Derangère V; Arnould L; Thibaudin M; Limagne E; Ghiringhelli F; Truntzer C; Ladoire S
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-specific gene regulatory networks subdivide intrinsic subtypes of breast cancer.
    Nasser S; Cunliffe HE; Black MA; Kim S
    BMC Bioinformatics; 2011 Mar; 12 Suppl 2(Suppl 2):S3. PubMed ID: 21489222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.
    Wu L; Liu Z; Xu J; Chen M; Fang H; Tong W; Xiao W
    Biomark Med; 2015; 9(11):1053-65. PubMed ID: 26501477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach.
    Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
    Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
    BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.